Spots Global Cancer Trial Database for unresectable or metastatic cancer of the pancreas
Every month we try and update this database with for unresectable or metastatic cancer of the pancreas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | NCT00035035 | Pancreatic Neop... Metastases, Neo... | GEMZAR ALIMTA | 18 Years - | Eli Lilly and Company |